Biological response to radiation therapy

被引：49

作者：

Turesson, I ^{[1
]}

Carlsson, J

Brahme, A

Glimelius, B

Zackrisson, B

Stenerlöw, B

机构：

[1] Univ Uppsala Hosp, Dept Oncol Radiol & Clin Immunol, SE-75185 Uppsala, Sweden

[2] Univ Uppsala Hosp, Unit Oncol, SE-75185 Uppsala, Sweden

[3] Univ Uppsala Hosp, Unit Biomed Radiat Sci, SE-75185 Uppsala, Sweden

[4] Karolinska Inst, Dept Pathol & Oncol, Stockholm, Sweden

[5] Umea Univ, Dept Oncol, Umea, Sweden

来源：

ACTA ONCOLOGICA | 2003年 / 42卷 / 02期

关键词：

D O I：

10.1080/02841860310004959

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

In an investigation by the Swedish Cancer Society, the present status, critical issues and future aspects and potentials were described by an expert group for each of nine major areas of radiation therapy research. This article deals with biological response to radiation. Separate sections deal with molecular responses to radiation. the stein cell and clonogenic cell concepts and the importance of cell proliferation. cell and tissue responses to doses above and below 1 Gy, respectively, the potential role of intercellular signalling pathways. the so-called bystander effect and radiation biology-based therapy planning and treatment optimization.

引用

页码：92 / 106

页数：15

共 70 条

[1]

Agren Cronqvist A K, 1995, Acta Oncol, V34, P851

[2]

AGRENCRONQUIST AK, 1995, THESIS STOCKHOLM U

[3] Does variability in normal tissue reactions after radiotherapy have a genetic basis - where and how to look for it? [J].

Andreassen, CN ;

Alsner, J ;

Overgaard, J .

RADIOTHERAPY AND ONCOLOGY, 2002, 64 (02) :131-140

[4]

[Anonymous], 1987, FRACTIONATION RADIOT

[5] Direct evidence for the participation of gap junction-mediated intercellular communication in the transmission of damage signals from α-particle irradiated to nonirradiated cells [J].

Azzam, EI ;

de Toledo, SM ;

Little, JB .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (02) :473-478

[6] Stem cells: the intestinal stem cell as a paradigm [J].

Bach, SP ;

Renehan, AG ;

Potten, CS .

CARCINOGENESIS, 2000, 21 (03) :469-476

[7] The value of pretreatment cell kinetic parameters as predictors for radiotherapy outcome in head and neck cancer: a multicenter analysis [J].

Begg, AC ;

Haustermans, K ;

Hart, AAM ;

Dische, S ;

Saunders, M ;

Zackrisson, B ;

Gustaffson, H ;

Coucke, P ;

Paschoud, N ;

Hoyer, M ;

Overgaard, J ;

Antognoni, P ;

Richetti, A ;

Bourhis, J ;

Bartelink, H ;

Horiot, JC ;

Corvo, R ;

Giaretti, W ;

Awwad, H ;

Shouman, T ;

Jouffroy, T ;

Maciorowski, Z ;

Dobrowsky, W ;

Struikmans, H ;

Rutgers, D ;

Wilson, GD .

RADIOTHERAPY AND ONCOLOGY, 1999, 50 (01) :13-23

[8] Intensity-modulated radiotherapy: Current status and issues of interest [J].

Boyer, AL ;

Butler, EB ;

DiPetrillo, TA ;

Engler, MJ ;

Fraass, B ;

Grant, W ;

Ling, CC ;

Low, DA ;

Mackie, TR ;

Mohan, R ;

Purdy, JA ;

Roach, M ;

Rosenman, JG ;

Verhey, LJ ;

Wong, JW ;

Cumberlin, RL ;

Stone, H ;

Palta, JR .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2001, 51 (04) :880-914

[9] OPTIMAL DOSE DISTRIBUTION FOR ERADICATION OF HETEROGENEOUS TUMORS [J].

BRAHME, A ;

AGREN, AK .

ACTA ONCOLOGICA, 1987, 26 (05) :377-385

[10] Development of radiation therapy optimization [J].

Brahme, A .

ACTA ONCOLOGICA, 2000, 39 (05) :579-595

← 1 2 3 4 5 6 7 →